Astellas Pharma

Rediff.com » News » Astellas Pharma

News for Astellas Pharma

Business

Japanese pharma firm sets up Indian subsidiary

Astellas Pharma, the second largest Japanese drug company, has set up a wholly-owned subsidiary in India, making it the third Japanese pharma major after Daiichi Sankyo and Eisai to tap the growing......

US stops launch of Dr Reddy's drug

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis'......

Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008.This increase is despite......

It's destination India for Japan Inc!

India has become the most sought destination for investment by Japanese companies, next to China, and ahead of other Asian countries and emerging economies like Russia, Brazil, Mexico and even the......

India is growth tonic for mid-tier global pharma

Two months ago, Michigan-based Perrigo Company, one of the world's largest over-the-counter pharmaceutical producers with over $2 billion sales, acquired 85 per cent in Mumbai-based Vedants Drugs......

Web results for Astellas Pharma

Lesley Visser to Speak at Astellas Presents Executive Women's Day at the Crowne Plaza Invitational at Colonial

/PRNewswire/ --The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today... ...

http://in.advfn.com/p.php?pid=nmona&article=57663365

Nidec Corp. Tops Institutional Investor's Inaugural All-Japan Executive Team Survey

Nidec Corp., a Japanese maker of small precision motors for computer equipment, appliances and autos, has the top-ranked management among major... ...

http://www.andhranews.net/Business/2013/Nidec-Corp-Tops-Institutional-Investors-Inaugural-22067.htm

XenoPort to drop multiple sclerosis drug, shares fall

By Vrinda Manocha (Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in... ...

http://in.reuters.com/article/2013/05/20/us-xenoport-study-multiplesclerosis-idINBRE94J0BO20130520?feedType=RSS&feedName=health

Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash

/PRNewswire/ --Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the... ...

http://in.advfn.com/p.php?pid=nmona&article=57649491

TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map

/PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease... ...

http://www.itnewsonline.com/showprnstory.php?storyid=271461

See All

Rediff News

Astellas Pharma

News for Astellas Pharma

Japanese pharma firm sets up Indian subsidiary

US stops launch of Dr Reddy's drug

Indian drug makers maintain pace of US mktg nod

It's destination India for Japan Inc!

India is growth tonic for mid-tier global pharma

Related Pages

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog